Login / Signup
Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy-early promise but more data needed.
David J Gibson
Mark G Ward
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
big data
electronic health record
open label
ulcerative colitis
artificial intelligence
randomized controlled trial
data analysis